Scoring systems improve timing of cell transplant for MDS patients

06/27/2013 | MDSBeacon.com

The use of prognosis scoring systems to time donor stem cell transplantation may extend the lives of patients treated for myelodysplastic syndromes, according to a study in the American Journal of Hematology. Researchers in Italy found that delayed transplantation may be better for patients whose early illness is considered very low- or low-risk by the World Health Organization classification-based Prognostic Scoring System and low-risk by the International Prognostic Scoring System.

View Full Article in:

MDSBeacon.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC